NLA LOGO - USE.png
PCSK9 Barriers Survey Results Revealed at National Lipid Association Conference
February 07, 2017 09:30 ET | National Lipid Association
PHOENIX, AZ--(Marketwired - February 07, 2017) - As part of its Spring Clinical Lipid Update (CLU) in Phoenix, the National Lipid Association (NLA) will reveal the results of its "Challenges in...
Cholesterol-Lowering Injectables: More Harm Than Good, States Journal of American Physicians and Surgeons
December 14, 2015 08:49 ET | Association of American Physicians and Surgeons
TUCSON, Ariz., Dec. 14, 2015 (GLOBE NEWSWIRE) -- Newly approved cholesterol lowering agents, Repatha (evolocumab) and Praluent (alirocumab), are being heavily promoted as a new breakthrough in...